1-10 of 10
Sundar Jagannath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MRD-negative duration following latest line of therapy predicts long-term PFS in real-world multiple myeloma patients

Lucia Y Chen, Santiago Thibaud, Saoirse Bodnar, Ajai Chari, Joshua Richter, Hearn Jay Cho, Larysa J Sanchez, Cesar Rodriguez, Adriana C Rossi, Shambavi Richard, Samir Parekh, Sundar Jagannath
Journal: Blood Advances
Blood Adv bloodadvances.2024014097.
https://doi.org/10.1182/bloodadvances.2024014097
Published: 2024
Journal Articles

Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survival

Zachary M Avigan, Saoirse Bodnar, Darren Pan, Jerrel Lewis Catlett, II, Joshua Richter, Larysa J Sanchez, Cesar Rodriguez, Adriana C Rossi, Shambavi Richard, Sundar Jagannath, Hearn Jay Cho, Samir Parekh, Santiago Thibaud
Journal: Blood Advances
Blood Adv bloodadvances.2024014255.
https://doi.org/10.1182/bloodadvances.2024014255
Published: 2024
Includes: Supplemental data
Journal Articles

Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma

Mateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, Tarek H. Mouhieddine, Juan Esteban Velez-Hernandez, Katherine Engles, Joshua A. Fein, Jorge Monge, Cara Rosenbaum, Roger Pearse, David Jayabalan, Christian Gordillo, Hei Ton Chan, Samuel Yamshon, Santiago Thibaud, Markus Mapara, Giorgio Inghirami, Suzanne Lentzsch, Ran Reshef, Adriana Rossi, Samir Parekh, Sundar Jagannath, Shambavi Richard, Ruben Niesvizky, Mark Bustoros
Journal: Blood Advances
Blood Adv (2024) 8 (15): 3859–3869.
https://doi.org/10.1182/bloodadvances.2023012470
Published: 2024
Includes: Supplemental data
Journal Articles

Regression of smoldering myeloma with treatment of Gaucher disease

Kevin Barley, Anshuman Parekh, Syed Salam, Damodara Rao Mendu, Ravi Prakash Shukla, Deepa Vatti, Daniel Verina, Chanan Stauffer, Christian Salib, Siraj El Jamal, Julie Teruya-Feldstein, Amy S. Duffield, Violetta V. Leshchenko, Sundar Jagannath, Manisha Balwani, Samir Parekh
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1634–1638.
https://doi.org/10.1182/bloodadvances.2023012304
Published: 2024
Includes: Supplemental data
Journal Articles

Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups

Clinical Trials & Observations
Urvi A. Shah, Erin Moshier, Andriy Derkach, Yuanhui Huang, Sham Mailankody, Carlyn R. Tan, Kylee Maclachlan, Malin Hultcrantz, Neha Korde, Hani Hassoun, Santiago Thibaud, Larysa Sanchez, Cesar Rodriguez, Shambavi Richard, Joshua Richter, Adriana Rossi, Hearn Jay Cho, Alexander Lesokhin, Ajai Chari, Saad Z. Usmani, Sundar Jagannath, Samir Parekh, Emily J. Gallagher
Journal: Blood Advances
Blood Adv (2024) 8 (1): 236–247.
https://doi.org/10.1182/bloodadvances.2023010815
Published: 2024
Includes: Supplemental data
Journal Articles

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma

Tarek H. Mouhieddine, Oliver Van Oekelen, David T. Melnekoff, Jeanne Li, Yogita Ghodke-Puranik, Guido Lancman, Santiago Thibaud, Darren Pan, Sridevi Rajeeve, Sarita Agte, Adolfo Aleman, Larysa Sanchez, Shambavi Richard, Adriana Rossi, Joshua Richter, Hearn Jay Cho, Cesar Rodriguez, Alessandro Lagana, Erin Moshier, Ajai Chari, Sundar Jagannath, Samir Parekh
Journal: Blood Advances
Blood Adv (2023) 7 (6): 1056–1064.
https://doi.org/10.1182/bloodadvances.2022007923
Published: 2023
Includes: Supplemental data
Journal Articles

Renal response in real-world carfilzomib- vs bortezomib-treated patients with relapsed or refractory multiple myeloma

Clinical Trials & Observations
Shaji Kumar, Alan Fu, Ruben Niesvizky, Sundar Jagannath, Ralph Boccia, Noopur Raje
Journal: Blood Advances
Blood Adv (2021) 5 (2): 367–376.
https://doi.org/10.1182/bloodadvances.2019001059
Published: 2021
Includes: Supplemental data
Journal Articles

Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM

Clinical Trials & Observations
Sundar Jagannath, Rafat Abonour, Brian G. M. Durie, Mohit Narang, Howard R. Terebelo, Cristina J. Gasparetto, Kathleen Toomey, James W. Hardin, Lynne Wagner, Amit Agarwal, Shankar Srinivasan, Amani Kitali, E. Dawn Flick, Michael Sturniolo, Robert M. Rifkin
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1608–1615.
https://doi.org/10.1182/bloodadvances.2018017186
Published: 2018
Includes: Supplemental data
Journal Articles

Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modeling

Clinical Trials & Observations
Vernon Wu, Erin Moshier, Siyang Leng, Bart Barlogie, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Madhu Mazumdar, Samir Parekh, Ajai Chari
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1470–1479.
https://doi.org/10.1182/bloodadvances.2018016998
Published: 2018
Journal Articles

A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma

Clinical Trials & Observations
Ajai Chari, Hearn J. Cho, Amishi Dhadwal, Gillian Morgan, Lisa La, Katarzyna Zarychta, Donna Catamero, Erika Florendo, Nadege Stevens, Daniel Verina, Elaine Chan, Violetta Leshchenko, Alessandro Laganà, Deepak Perumal, Anna Huo-Chang Mei, Kaity Tung, Jami Fukui, Sundar Jagannath, Samir Parekh
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1575–1583.
https://doi.org/10.1182/bloodadvances.2017007427
Published: 2017
Includes: Supplemental data